• 2008

Company Description

Anaphore develops protein therapeutics that address unmet medical needs of patients with life-threatening diseases.

Anaphore (formerly ImmunoNewCo) is developing a new class of protein therapeutics to address significant unmet medical needs for patients with serious or life-threatening diseases.